Esperion Therapeutics (ESPR)
(Delayed Data from NSDQ)
$2.34 USD
0.00 (0.00%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $2.37 +0.03 (1.28%) 6:18 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO8/6/24 |
---|---|
Current Quarter | -0.14 |
EPS Last Quarter | 0.34 |
Last EPS Surprise | 525.00% |
ABR | 2.00 |
Earnings ESP
|
64.29% |
---|---|
Current Year | 0.03 |
Next Year | 0.32 |
EPS (TTM) | -0.99 |
P/E (F1) | 70.20 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 51.12M | 58.07M | 321.01M | 484.77M |
# of Estimates | 5 | 5 | 5 | 4 |
High Estimate | 68.96M | 73.30M | 384.50M | 664.80M |
Low Estimate | 37.80M | 47.29M | 282.37M | 402.15M |
Year ago Sales | 25.79M | 33.97M | 116.33M | 321.01M |
Year over Year Growth Est. | 98.22% | 70.95% | 175.94% | 51.02% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.14 | -0.14 | 0.03 | 0.32 |
# of Estimates | 6 | 5 | 6 | 5 |
Most Recent Consensus | -0.23 | -0.14 | -0.23 | -0.01 |
High Estimate | -0.01 | -0.05 | 0.60 | 1.18 |
Low Estimate | -0.25 | -0.21 | -0.23 | -0.21 |
Year ago EPS | -0.46 | -0.37 | -2.03 | 0.03 |
Year over Year Growth Est. | 69.57% | 62.16% | 101.48% | 955.56% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 0 | 2 | 1 |
Up Last 60 Days | 2 | 0 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 1 |
Down Last 60 Days | 0 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.14 | -0.14 | 0.03 | 0.32 |
7 Days Ago | -0.14 | -0.14 | 0.03 | 0.32 |
30 Days Ago | -0.18 | -0.11 | -0.05 | 0.33 |
60 Days Ago | -0.18 | -0.11 | -0.05 | 0.32 |
90 Days Ago | -0.23 | -0.15 | -0.55 | 0.31 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.05 | -0.21 | 0.23 | -0.04 |
Zacks Consensus Estimate | -0.14 | -0.14 | 0.03 | 0.32 |
Earnings ESP | 64.29% | -50.00% | 590.01% | -112.50% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.34 | -0.50 | -0.37 | -0.46 | NA |
Estimate | -0.08 | -0.53 | -0.42 | -0.63 | NA |
Difference | 0.42 | 0.03 | 0.05 | 0.17 | 0.17 |
Surprise | 525.00% | 5.66% | 11.90% | 26.98% | 142.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more